Santé publique : le contrôle des maladies méningococciques au Québec
Open Access
- 15 October 2003
- journal article
- abstracts
- Published by EDP Sciences in médecine/sciences
- Vol. 19 (10) , 1011-1015
- https://doi.org/10.1051/medsci/200319101011
Abstract
A first outbreak of serogroup C meningococcal disease occurred in the province of Quebec in 1990-1992 and lead to a mass immunization campaign using polysaccharide vaccines. In 2001, a second outbreak was identified and a mass vaccination campaign was carried out, using the newly licensed conjugate vaccine. Clinical, epidemiological, economic and social studies were instrumental in the decision making for implementing these control programs.Keywords
This publication has 12 references indexed in Scilit:
- Economic analysis of the 1992–1993 mass immunization campaign against serogroup C meningococcal disease in QuebecVaccine, 2002
- Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success storyVaccine, 2001
- Meningococcal VaccinesPublished by Springer Nature ,2001
- Immunogenicity of bivalent AC polysaccharide meningococcal vaccine in children aged 6 through 24 months.JAMA, 2001
- Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.JAMA, 2001
- Evaluation of the Completeness of Reporting of Invasive Meningococcal DiseaseCanadian Journal of Public Health, 1999
- Complications and Sequelae of Meningococcal Disease in Quebec, Canada, 1990–1994Clinical Infectious Diseases, 1998
- Recent changes in meningococcal disease in EuropeEurosurveillance, 1997
- Thymus-Independent and Thymus-Dependent Responses to Polysaccharide AntigensThe Journal of Infectious Diseases, 1992
- Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in CanadaJournal of Clinical Microbiology, 1991